Health Insurance Innovations (NASDAQ:HIIQ) Price Target Cut to $40.00

Share on StockTwits

Health Insurance Innovations (NASDAQ:HIIQ) had its price objective lowered by equities research analysts at Craig Hallum from $50.00 to $40.00 in a note issued to investors on Friday, The Fly reports. The firm presently has a “buy” rating on the financial services provider’s stock. Craig Hallum’s price target would suggest a potential upside of 111.42% from the stock’s current price. The analysts noted that the move was a valuation call.

A number of other research firms have also weighed in on HIIQ. ValuEngine lowered Health Insurance Innovations from a “hold” rating to a “sell” rating in a report on Monday, November 4th. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 price target on shares of Health Insurance Innovations in a report on Tuesday, November 26th. BidaskClub upgraded Health Insurance Innovations from a “strong sell” rating to a “sell” rating in a report on Saturday, November 30th. Zacks Investment Research upgraded Health Insurance Innovations from a “sell” rating to a “hold” rating in a report on Tuesday, November 19th. Finally, Raymond James lowered Health Insurance Innovations from an “outperform” rating to a “market perform” rating in a report on Monday, November 18th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $48.43.

HIIQ stock opened at $18.92 on Friday. Health Insurance Innovations has a twelve month low of $15.95 and a twelve month high of $46.60. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 1.36. The stock’s 50 day moving average is $21.81 and its 200-day moving average is $22.81. The firm has a market capitalization of $276.64 million, a PE ratio of 8.97 and a beta of 1.36.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Tuesday, November 12th. The financial services provider reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.52. Health Insurance Innovations had a return on equity of 29.73% and a net margin of 3.93%. The company had revenue of $75.27 million for the quarter, compared to analyst estimates of $91.23 million. During the same quarter last year, the company earned $0.61 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. On average, equities research analysts anticipate that Health Insurance Innovations will post 3.49 earnings per share for the current fiscal year.

In related news, major shareholder Michael W. Kosloske sold 52,829 shares of Health Insurance Innovations stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.37, for a total transaction of $970,468.73. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder Michael W. Kosloske sold 6,250 shares of Health Insurance Innovations stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.14, for a total value of $119,625.00. Insiders have sold 368,629 shares of company stock worth $6,764,145 over the last quarter. 47.88% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently modified their holdings of HIIQ. P2 Capital Partners LLC raised its stake in shares of Health Insurance Innovations by 2,666.7% in the second quarter. P2 Capital Partners LLC now owns 830,000 shares of the financial services provider’s stock valued at $21,514,000 after buying an additional 800,000 shares during the period. Nuveen Asset Management LLC bought a new stake in shares of Health Insurance Innovations in the second quarter valued at $12,981,000. Capital Returns Management LLC raised its stake in shares of Health Insurance Innovations by 148.2% in the second quarter. Capital Returns Management LLC now owns 406,966 shares of the financial services provider’s stock valued at $10,549,000 after buying an additional 242,981 shares during the period. Vanguard Group Inc. raised its stake in shares of Health Insurance Innovations by 18.8% in the second quarter. Vanguard Group Inc. now owns 903,937 shares of the financial services provider’s stock valued at $23,430,000 after buying an additional 143,054 shares during the period. Finally, AQR Capital Management LLC raised its stake in shares of Health Insurance Innovations by 573.1% in the second quarter. AQR Capital Management LLC now owns 98,978 shares of the financial services provider’s stock valued at $2,566,000 after buying an additional 84,273 shares during the period. Hedge funds and other institutional investors own 85.26% of the company’s stock.

About Health Insurance Innovations

Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provide 3 months to 12 months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer fixed cash benefits and additional benefits for procedures and services; and supplemental insurance products, including life insurance policies, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and pharmacy benefit cards.

Further Reading: How To Calculate Debt-to-Equity Ratio

The Fly

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Abbott Laboratories  Updates FY 2020
Pre-Market Earnings Guidance
Abbott Laboratories Updates FY 2020 Pre-Market Earnings Guidance
Express  Releases Q4 2019
Pre-Market Earnings Guidance
Express Releases Q4 2019 Pre-Market Earnings Guidance
MarineMax  Updates FY20 Earnings Guidance
MarineMax Updates FY20 Earnings Guidance
Squar Milner Financial Services LLC Cuts Position in Invesco BulletShares 2022 Corporate Bond ETF
Squar Milner Financial Services LLC Cuts Position in Invesco BulletShares 2022 Corporate Bond ETF
Vanguard Russell 2000  Stock Position Trimmed by Janney Montgomery Scott LLC
Vanguard Russell 2000 Stock Position Trimmed by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC Has $14.72 Million Stake in L3Harris
Janney Montgomery Scott LLC Has $14.72 Million Stake in L3Harris


 
© 2006-2020 Zolmax.